Infectious Diseases - PART 3 Flashcards
DAPTOMYCIN COVERAGE
MOST GP BACTERIA (MRSA, VRE)
NO GN ACTIVITY
WHEN SHOULD YOU NOT USE DAPTOMYCIN
PNEUMONIA
INACTIVATED BY LUNG SURFACTANT
DAPTOMYCIN INDICATIONS
SSTI
STAPH BLOODSTREAM INFECTIONS (MRSA)
ENDOCARDITIS
DAPTOMYCIN WARNING
MYOPATHY AND RHABDOMYOLYSIS
FALSE ↑ PT/INR
LINEZOLID COVERAGE
MRSA AND VRE
LINEZOLID RENAL DOSE ADJUSTMENT?
NOT NEEDED
LINEZOLID BIOAVAILABILITY
IV:PO 1:1
LINEZOLID CONTRAINDICATION
DO NOT USE WITHIN 2 WEEKS OF MAOI
LINEZOLID WARNING
DURATION RELATED MYELOSUPPRESSION (THROMBOCYTOPENIA)
OPTIC NEUROPATHY
SEROTONIN SYNDROME
HYPOGLYCEMIA
LINEZOLID SUSPENSION. ADMINISTRATION
DO NOT SHAKE
QUINUPRISTIN/DALFOPRISTIN SIDE EFFECTS
ARTHRALGIAS/MYALGIAS
INFUSION REACTIONS
HYPERBILIRUBINEMIA
QUINUPRISTIN/DALFOPRISTIN ADMINISTRATION
DILUTE WITH D5W ONLY
ADMINISTER VIA CENTRAL LINE ONLY
TIGECYCLINE COVERAGE
BROAD SPECTRUM GP (MRSA, VRE)
GN BACTERIA, ANAEROBES, ATYPICAL
QUINUPRISTIN/DALFOPRISTIN COVERAGE
MRSA
VRE (BUT NOT E.FAECALIS)
QUINUPRISTIN/DALFOPRISTIN IS NOT WELL TOLERATED, SO ONLY USED FOR THIS INFECTION
VRE E.FAECIUM INFECTIONS
TIGECYCLINE DOES NOT HAVE COVERAGE TO
3 P’S
PSEUDOMONAS
PROTEUS
PROVIDENCIA
TIGECYCLINE HAS LIMITED USES
WHAT ARE THE INDICATIONS?
COMPLICATED SSTI
INTRA-AB INFECTION
CA-PNEUMONIA
TIGECYCLINE BOXED WARNING
↑ RISK OF DEATH
ONLY USE WHEN NECESSARY
DO NOT USE TIGECYCLINE FOR THSES INFECTIONS
BLOODSTREAM INFECTIONS
DOES NOT ACHIEVE ADEQUATE CONCENTRATIONS
WHAT COLOR SHOULD TIGECYCLINE BE WHEN RECONSTITUTED
YELLOW-ORANGE COLOR
POLYMIXINS ARE PRIMARILY USED FOR
MDR GRAM NEGATIVE PATHOGENS